Vericiguat
id:
vericiguat-180-8510669
title:
Vericiguat
text:
Vericiguat, sold under the brand name Verquvo, is a medication used to reduce the risk of cardiovascular death and hospitalization in certain patients with heart failure after a recent acute decompensation event. It is taken by mouth. Vericiguat is a soluble guanylate cyclase (sGC) stimulator. Common side effects include low blood pressure and low red cell count (anemia). It was approved for medical use in the United States in January 2021, and for use in the European Union in July 2021. The U.S
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Vericiguat
date created:
2021-01-20T07:48:16Z
date modified:
2024-09-05T12:30:53Z
main entity:
{"identifier":"Q27283201","url":"https://www.wikidata.org/entity/Q27283201"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a3/Vericiguat_Structural_formula_V1.svg","width":381,"height":486}
fields total:
13
integrity:
16